Company News for Dec 10, 2019

FATE CGC

  • Shares of ArQule, Inc. jumped 103.9% after Merck & Co., Inc. said it would buy the company in a deal worth $2.7 billion
  •  Shares of Synthorx, Inc. soared 170.5% after Sanofi SA said that it will acquire the company for an aggregated equity value of around $2.5 billion
  • Shares of Canopy Growth Corporation (CGC - Free Report) rose 14.2% after the company announced David Klein as the new CEO
  • Shares of Fate Therapeutics, Inc. (FATE - Free Report) rose 41.3% after the company announced positive preliminary data from its FT596 study

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>